[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364191-105":59,"doc-detail-364191-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ex-vivo-immuno-oncology-platform-reveals-spatial-t-cell-infiltration-patterns-linked-to-atr-inhibition-responses-in-high-grade-serous-ovarian-cancer","Ex Vivo Immuno-Oncology Platform Reveals Spatial T Cell Infiltration Patterns Linked to ATR Inhibition Responses in High-Grade Serous Ovarian Cancer","","Identifying new therapeutic approaches in high-grade serous ovarian cancer (HGSC) requires patient-specific preclinical models that reflect tumor biology and the microenvironment. The study established immunocompetent patient-derived cultures (iPDCs) grown on a physiologically relevant omentum-gel matrix. A high-throughput workflow combined drug testing, histology, genomic profiling, single-cell analyses, and spatial biomarker discovery. Across 47 tumors, iPDCs preserved tumor genomic/histological features and retained intratumoral immune cells. Treatment responses matched clinical responses, enabling ATRi-linked, state-specific options for recurrent HGSC, including ATRi plus immunotherapy targeting Autotaxin, associated with increased T-cell infiltration and spatial interactions driving CD8+ reactivation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ex-vivo-immuno-oncology-platform-reveals-spatial-t-cell-infiltration-patterns-linked-to-atr-inhibition-responses-in-high-grade-serous-ovarian-cancer/364191/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ex-vivo-immuno-oncology-platform-reveals-spatial-t-cell-infiltration-patterns-linked-to-atr-inhibition-responses-in-high-grade-serous-ovarian-cancer/364191.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What model did the study develop for HGSC research?","Question",{"text":112,"@type":113},"The study established immunocompetent patient-derived cultures (iPDCs) for HGSC, cultured on a physiologically relevant human omentum-gel matrix to better replicate the patient tumor and microenvironment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What did the researchers find about iPDC treatment responses?",{"text":117,"@type":113},"In 47 tumors, iPDCs recapitulated tumor genomic and histological characteristics while retaining intratumoral immune cells, and the iPDC treatment responses significantly correlated with patients’ clinical treatment responses.",{"name":119,"@type":110,"acceptedAnswer":120},"How were ATR inhibitor responses linked to immune changes?",{"text":121,"@type":113},"Using hyperplexed imaging and spatial analysis, the study found ATRi responses associated with significant increases in intra- and peritumoral T cell infiltration, especially PD1+ CD8+ T cells, alongside reactivation of CD8+ T cells linked to spatial interactions with replication stress–positive tumor cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364191,1790272412,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Europe PMC unders uthManuscripts Europe M eC und Author Manuscripts  \nEurope PMC Funders Group  \nAuthor Manuscript  \nCancer Immunol Res. Author manuscript; available in PMC 2026 March 10.  \nPublished in final edited form as:  \nCancer Immunol Res. 2026 January 21; 14(4): 625–639. doi:10.1158/2326-6066.CIR-25-0743 .  \nEx Vivo Immuno-Oncology Platform Reveals Spatial T Cell Infiltration Patterns Linked to ATR Inhibition Responses in HighGrade Serous Ovarian Cancer  \nAshwini S Nagaraj 1 , Matilda Salko\\#1 , Aditi Sirsikar\\#1 , Ziqi Kang 1 , Erdogan Pekcan Erkan 1,2 , Elina A Pietilä 1 , Iga Niemiec 1 , Jie Bao 1 , Giovanni Marchi 1 , Angéla Szabó 1 , María Hincapié-Otero 1 , Anastasia Lundgren 1 , Kirsten Nowlan3 , Sanna Pikkusaari 1 , Anna Kanerva4 , Johanna Tapper4 , Riitta Koivisto-Korander4 , Heini Lassus 1,4 , Liisa Kauppi 1 , Sampsa Hautaniemi 1 , Anna Vähärautio 1,5 , Jing Tang 1 , Eliisa Kekäläinen3,6 , Ulla-Maija Haltia 1,4 , Anni Virtanen 1,7 , Joonas Jukonen 1 , Tuula Salo8,9,10,11 , Anniina Färkkilä 1,12,13,14,*  \n1 Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.  \n2 Faculty of Medicine and Health Technology, Tampere University and TAYS Cancer Centre, Tampere, Finland.  \n3 Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.  \n4 Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.  \n5 Foundation for the Finnish Cancer Institute, Finland  \n6Translational Immunology Research Program, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.  \n7 Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.  \n8 Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.  \n9 Department of Pathology, HUSLAB, Helsinki University Hospital, Helsinki, Finland.  \n10 Unit of Population Health, Medical Research Center Oulu, Finland  \n11 University of Oulu and Oulu University Hospital, Oulu, Finland.  \nThis work is licensed under a BY 4.0 International license.  \n*Correspondence: Anniina Färkkilä . [anniina.farkkila@helsinki.fi](anniina.farkkila@helsinki.fi).  \nAuthors’ Contributions  \nConceptualization: A.F.  \nMethodology: A.S.N., M.S., A.Si., E.P.E. Z.K., E.A.P., I.N., J.B., G.M., A.L., K.N., S.P., T.S.  \nInvestigation: A.S.N., M.S., A.Si., Z.K., A. Vi. Visualization: A.S.N., M.S., A.Si., E.P.E., Z.K., I.N., G.M.  \nPatient recruitment and patient sample acquisition: A.K., J.T., R.K.K., U.M.H., H.L.  \nSupervision: S.H., A.Vä ., J.T., E.K., L.K., T.S., A.F.  \nWriting original draft: A.S.N., M.S., A.Si, E.P.E., G.M., A.F.  \nWriting review & editing: All the authors  \nConflict of interest: Authors declare that they have no conflict of interest.  \nFunding information: This study was co-funded by The European Union (ERC, SPACE 101076096), Sigrid Jusélius Foundation, Cancer Society of Finland, Research council of Finland (grant numbers 1339805, 350396, 351196) .  \nEurope PMC unders uthManuscripts Europe M eC und Author Manuscripts  \nNagaraj et al. Page 2  \n12 Department of Obstetrics and Gynecology, and Clinical trials unit, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland.  \n13iCAN digital precision cancer medicine, Helsinki, Finland  \n14 Institute for Molecular Medicine Finland, Helsinki Institute of Life Sciences, University of Helsinki, Finland.  \n\\# These authors contributed equally to this work.  \nAbstract  \nIdentifying new therapeutic approaches in high-grade serous ovarian cancer (HGSC) requires the development of more accurate preclinical models that replicate the patient-specific tumor and its microenvironment. To address this, we established immunocompetent patient-derived cultures (iPDCs) for HGSC, cultured on a physiologically relevant human omentum-gel matrix.  \nWe developed a high-throughput platform that combines drug testing, histological analysis, genomic profili","cbCaij4OkdDIALmY","https://ap.wps.com/l/cbCaij4OkdDIALmY","pdf",2405179,31,"English","# Abstract\n# Introduction","[{\"question\":\"What model did the study develop for HGSC research?\",\"answer\":\"The study established immunocompetent patient-derived cultures (iPDCs) for HGSC, cultured on a physiologically relevant human omentum-gel matrix to better replicate the patient tumor and microenvironment.\"},{\"question\":\"What did the researchers find about iPDC treatment responses?\",\"answer\":\"In 47 tumors, iPDCs recapitulated tumor genomic and histological characteristics while retaining intratumoral immune cells, and the iPDC treatment responses significantly correlated with patients’ clinical treatment responses.\"},{\"question\":\"How were ATR inhibitor responses linked to immune changes?\",\"answer\":\"Using hyperplexed imaging and spatial analysis, the study found ATRi responses associated with significant increases in intra- and peritumoral T cell infiltration, especially PD1+ CD8+ T cells, alongside reactivation of CD8+ T cells linked to spatial interactions with replication stress–positive tumor cells.\"}]","Ex Vivo Immuno-Oncology Platform Reveals Spatial T Cell Infiltration Patterns Linked to ATR Inhibition Responses in High-Grade Serous Ovarian Cancer | PDF",1790156301,78,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3374818d4ed5ecadc2576bf0671efbd5.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5282c3f8f1a534c90cd5d41f107a3394.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/925b04228e2d64bcfe248bcba21c404d.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/445c6355ab47c17650a3de52fbb46613.webp",980,1268]